Get started
Author

Mikael Elofsson

Observed names: Elofsson, M., Elofsson, Mikael, M Elofsson, M. ELOFSSON, M. Elofsson, MIKAEL ELOFSSON, Michael Elofsson
Observed institutions: California Institute of Technology, Lund University, Washington University in St. Louis, Yale University, European Molecular Biology Laboratory, AstraZeneca (Sweden), Umeå Centre for Microbial Research, Indian Institute of Chemical Technology, Umeå University
ORCID: 0000-0002-3219-4669
Observed ORCID: 0000-0002-3219-4669
OpenAlex ID: A5072343210
Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity
1999 · Lihao Meng, Royce Mohan, et al. · Proceedings of the National Academy of Sciences · 942
The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IκB kinase
2001 · Benjamin H.B. Kwok, Brian Koh, et al. · Chemistry & Biology · 522
PDF
Targeting Bacterial Virulence
2003 · Anna M Kauppi, Roland Nordfelth, et al. · Chemistry & Biology · 234
PDF
Small-Molecule Inhibitors Specifically Targeting Type III Secretion
2005 · R. Nordfelth, A. M. Kauppi, et al. · Infection and Immunity · 218
PDF
Total synthesis of the-potent proteasome inhibitor epoxomicin: a useful tool for understanding proteasome biology
1999 · Ny Sin, Kyung Bo Kim, et al. · Bioorganic & Medicinal Chemistry Letters · 211
A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis
2006 · Sandra Muschiol, Leslie Bailey, et al. · Proceedings of the National Academy of Sciences · 192
Virulence blockers as alternatives to antibiotics: type III secretion inhibitors against Gram‐negative bacteria
2008 · P. Keyser, M. Elofsson, et al. · Journal of Internal Medicine · 158
PDF
Towards subunit-specific proteasome inhibitors: synthesis and evaluation of peptide α', β'-epoxyketones
1999 · Mikael Elofsson, Ute Splittgerber, et al. · Chemistry & Biology · 153
PDF
Inhibition of Type III Secretion inSalmonella entericaSerovar Typhimurium by Small-Molecule Inhibitors
2007 · Debra L. Hudson, Abigail N. Layton, et al. · Antimicrobial Agents and Chemotherapy · 135
Derivatization Procedures for Reducing Oligosaccharides, Part 3: Preparation of Oligosaccharide Glycosylamines, and Their Conversion Into Glycosaccharide - Acrylamide Copolymers
1989 · Elisabeth Kallin, Hans Lönn, et al. · Journal of Carbohydrate Chemistry · 117
Salicylidene Acylhydrazides That Affect Type III Protein Secretion inSalmonella entericaSerovar Typhimurium
2007 · Aurel Negrea, Eva Bjur, et al. · Antimicrobial Agents and Chemotherapy · 115
Small molecule inhibitors of type III secretion in Yersinia block the Chlamydia pneumoniae infection cycle
2007 · Leslie Bailey, Åsa Gylfe, et al. · FEBS Letters · 107
PDF
Preparation of building blocks for glycopeptide synthesis by glycosylation of Fmoc amino acids having unprotected carboxyl groups
1995 · Lourdes A. Salvador, Mikael Elofsson, et al. · Tetrahedron · 100
Glycopeptides bind MHC molecules and elicit specific T cell responses.
1993 · C V Harding, J Kihlberg, et al. · The Journal of Immunology · 100
Identification of Bacterial Target Proteins for the Salicylidene Acylhydrazide Class of Virulence-blocking Compounds
2011 · Dai Wang, Caroline E. Zetterström, et al. · Journal of Biological Chemistry · 93
PDF
Building blocks for glycopeptide synthesis: glycosylation of 3-mercaptopropionic acid and Fmoc amino acids with unprotected carboxyl groups
1991 · Mikael Elofsson, Björn Walse, et al. · Tetrahedron Letters · 90
Removal of Acyl Protective Groups from Glycopeptides: Base Does Not Epimerize Peptide Stereocenters, and β-Elimination Is Slow
1996 · Petter Sjölin, Mikael Elofsson, et al. · The Journal of Organic Chemistry · 83
Preparation of Tn and sialyl Tn building blocks used in Fmoc solid-phase synthesis of glycopeptide fragments from HIV gp120
1997 · Mikael Elofsson, Lourdes A. Salvador, et al. · Tetrahedron · 82
Reversal of the Antichlamydial Activity of Putative Type III Secretion Inhibitors by Iron
2007 · Anatoly Slepenkin, Per-Anders Enquist, et al. · Infection and Immunity · 78
The Resveratrol Tetramer (-)-Hopeaphenol Inhibits Type III Secretion in the Gram-Negative Pathogens Yersinia pseudotuberculosis and Pseudomonas aeruginosa
2013 · Caroline E. Zetterström, Jenny Hasselgren, et al. · PLoS ONE · 75
PDF
Characterization of the Effects of Salicylidene Acylhydrazide Compounds on Type III Secretion in Escherichia coli O157:H7
2009 · Jai J. Tree, Dai Wang, et al. · Infection and Immunity · 70
Design, Synthesis, and Multivariate Quantitative Structure−Activity Relationship of SalicylanilidesPotent Inhibitors of Type III Secretion inYersinia
2007 · Markus K. Dahlgren, Anna M. Kauppi, et al. · Journal of Medicinal Chemistry · 69
Inhibitory Activity of the Isoflavone Biochanin A on Intracellular Bacteria of Genus Chlamydia and Initial Development of a Buccal Formulation
2014 · Leena Hanski, Natalja Genina, et al. · PLoS ONE · 65
PDF
Statistical molecular design of a focused salicylidene acylhydrazide library and multivariate QSAR of inhibition of type III secretion in the Gram-negative bacterium Yersinia
2010 · Markus K. Dahlgren, Caroline E. Zetterström, et al. · Bioorganic & Medicinal Chemistry · 62
Derivatives of 8-hydroxyquinoline—antibacterial agents that target intra- and extracellular Gram-negative pathogens
2012 · Per-Anders Enquist, Åsa Gylfe, et al. · Bioorganic & Medicinal Chemistry Letters · 61
Works count: 175
Citation count: 6,501
H-index: 40
I10-index: 102
Year
Topic
Type